Aytu Biopharma (AYTU) Non-cash Items (2018 - 2026)

Aytu Biopharma (AYTU) has 9 years of Non-cash Items data on file, last reported at $149336.0 in Q1 2026.

• Non-cash Items for Q1 2026 came in at $149336.0, down 25.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $149336.0 (down 25.33% YoY), and the FY2025 annual result was $100195.0, down 49.9% from the prior year.
• Non-cash Items climbed to $149336.0 in Q1 2026 per AYTU's latest filing, from $100000.0 in the prior quarter.
• Over five years, Non-cash Items peaked at $300000.0 in Q3 2023 and troughed at $2666.0 in Q3 2022.
• A 5-year average of $114888.2 and a median of $100000.0 in 2023 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items sank 94.44% in 2022, then jumped 11152.81% in 2023.
• A 5-year view of Non-cash Items shows it stood at $200000.0 in 2022, then slumped by 89.76% to $20470.0 in 2023, then surged by 297.65% to $81399.0 in 2024, then rose by 22.85% to $100000.0 in 2025, then soared by 49.34% to $149336.0 in 2026.
• Business Quant data shows AYTU's Non-cash Items at $149336.0 in Q1 2026, $100000.0 in Q4 2025, and $103898.0 in Q3 2025.